Clinical Trial

Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator

Study acronym: RESCUE-SHOCK
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is a prospective, open-label, two-arm, randomized multicenter trial to identify whether immediate multi-vessel PCI would be better in clinical outcomes compared with culprit lesion-only PCI for AMI and multi-vessel disease with an advanced form of CS patients who require veno-arterial extracorporeal membrane oxygenator (VA-ECMO).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-08-31; most recent amendment 2024-11-04.
Status change: Not Yet Recruiting → Recruiting 2022-12-19
Trial Details
NCT Number NCT05527717
Lead Sponsor Samsung Medical Center
Conditions Cardiogenic Shock, Acute Myocardial Infarction, Multi Vessel Coronary Artery Disease, Extracorporeal Membrane Oxygenation
Enrollment 560 participants
Start Date 2022-11-16
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-06